losartan at1 antagonist prevents aortic aneurysm mouse model marfan syndrome
aortic aneurysm dissection manifestations marfan syndrome mfs disorder caused mutations gene encodes fibrillin- selected manifestations mfs reflect excessive signaling transforming growth factor-beta tgf-beta family cytokines show aortic aneurysm mouse model mfs associated increased tgf-beta signaling can prevented tgf-beta antagonists tgf-beta-neutralizing antibody angiotensin ii type receptor at1 blocker losartan at1 antagonism also partially reversed noncardiovascular manifestations mfs including impaired alveolar septation data suggest losartan drug already clinical use hypertension merits investigation therapeutic strategy patients mfs potential prevent major life-threatening manifestation disorder
